| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
4,409 |
4,256 |
$553K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
15,265 |
13,351 |
$473K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,904 |
4,649 |
$421K |
| S9083 |
Global fee urgent care centers |
4,264 |
3,691 |
$397K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,608 |
6,101 |
$364K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
6,697 |
6,641 |
$346K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
3,147 |
3,131 |
$269K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,988 |
1,600 |
$136K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
5,432 |
4,703 |
$135K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
5,083 |
5,022 |
$132K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
2,016 |
1,615 |
$46K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
3,379 |
2,526 |
$37K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,220 |
972 |
$20K |
| 0001A |
|
362 |
358 |
$14K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
860 |
838 |
$14K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,506 |
1,872 |
$13K |
| 0124A |
|
258 |
256 |
$10K |
| 0002A |
|
227 |
224 |
$9K |
| 0134A |
|
189 |
184 |
$7K |
| 99215 |
Prolong outpt/office vis |
61 |
61 |
$7K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
46 |
46 |
$7K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
203 |
198 |
$5K |
| 0011A |
|
130 |
129 |
$5K |
| 0051A |
|
112 |
112 |
$4K |
| 90674 |
|
176 |
176 |
$4K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,723 |
2,667 |
$4K |
| 0052A |
|
92 |
91 |
$4K |
| 0071A |
|
78 |
78 |
$3K |
| M0247 |
Intravenous infusion, sotrovimab, includes infusion and post administration monitoring |
13 |
13 |
$3K |
| 90707 |
|
26 |
26 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
297 |
288 |
$2K |
| 99051 |
|
4,236 |
4,010 |
$2K |
| 81000 |
|
1,181 |
1,158 |
$2K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
33 |
33 |
$2K |
| 99205 |
Prolong outpt/office vis |
13 |
13 |
$2K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
35 |
29 |
$1K |
| 81025 |
|
1,467 |
1,421 |
$1K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
206 |
203 |
$1K |
| 0004A |
|
21 |
21 |
$838.49 |
| 71046 |
Radiologic examination, chest; 2 views |
34 |
34 |
$774.78 |
| 93000 |
|
55 |
55 |
$509.93 |
| 36415 |
Collection of venous blood by venipuncture |
931 |
914 |
$373.80 |
| 86580 |
|
56 |
51 |
$215.05 |
| 90686 |
|
61 |
61 |
$55.54 |
| 90611 |
|
17 |
15 |
$14.70 |
| 81002 |
|
106 |
101 |
$11.27 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
13 |
13 |
$0.56 |
| 90622 |
|
26 |
25 |
$0.00 |